Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 3Stomach Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Tongue Squamous Cell Carcinoma 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Resectable Esophageal Squamous Cell Carcinoma 1Rare Tumour 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Hypoxia 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Biliary Tract Neoplasms 1Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

sintilimab 1Endostatins 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Squamous Non-Small Cell Lung Cancer SqNSCLC × Albumin-Bound Paclitaxel × Clear all
NCT06747169 2024-12-27

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

Second Affiliated Hospital of Zunyi Medical University

Phase 2 Not yet recruiting
32 enrolled
Thoracic

Squamous Non-Small Cell Lung Cancer SqNSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡